Validation Data Gallery
|Positive WB detected in||SH-SY5Y cells|
|Positive IHC detected in||mouse pancreas tissue, human prostate cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||mouse pancreas tissue|
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
The immunogen of 20357-1-AP is Secretogranin II Fusion Protein expressed in E. coli.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Secretogranin II fusion protein Ag14215|
|Full Name||secretogranin II (chromogranin C)|
|Calculated molecular weight||617 aa, 71 kDa|
|Observed molecular weight||71 kDa|
|GenBank accession number||BC022509|
|Gene ID (NCBI)||7857|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
SCG2, also known as secretogranin II or Chromogranin C, is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is widely distributed in nervous and endocrine tissues, and abundant in neuroendocrine granules. In the brain secretogranin II is almost completely processed to secretoneurin, a peptide involved in neurite outgrowth, neuroprotection and neuronal plasticity.
|Product Specific Protocols|
|WB protocol for Secretogranin II antibody 20357-1-AP||Download protocol|
|IHC protocol for Secretogranin II antibody 20357-1-AP||Download protocol|
|IF protocol for Secretogranin II antibody 20357-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Front Mol Biosci
Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts.
Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1α in colorectal cancer.
J Cell Biol
SNX5 targets a monoamine transporter to the TGN for assembly into dense core vesicles by AP-3.
Gut microbiota shapes social dominance through modulating HDAC2 in the medial prefrontal cortex.